Filter
54
Filtered Results: 54
Text search:
L.
Mofenson
Featured
Recommendations
3
New Publications
4
Language
Document type
No document type
36
Studies & Reports
8
Guidelines
7
Manuals
3
Countries / Regions
Africa
3
Thailand
2
Kenya
2
Zimbabwe
2
Zambia
2
Lesotho
1
Rwanda
1
Cameroon
1
Senegal
1
Malawi
1
Haiti
1
Tanzania
1
Côte d’Ivoire / Ivory Coast
1
Uganda
1
Brazil
1
Ethiopia
1
Eswatini/ Swaziland
1
Authors & Publishers
Publication Years
Category
Clinical Guidelines
9
Countries
5
Women & Child Health
2
Public Health
1
Toolboxes
HIV
39
TB
5
COVID-19
3
Mental Health
1
The goal of this Global Action Plan is to articulate synergistic actions that will be required to prevent HIVDR from undermining efforts to achieve global targets on health and HIV, and to provide the most effective treatment to all people living with HIV including adults, key populations, pregnant ...
Supplement Article
J Acquir Immune Defic Syndr Volume 78, Supplement 1, August 15, 2018 www.jaids.com
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Division of Tuberculosis Elimination
Accessed: 08.10.2019
Downloaded from https://aidsinfo.nih.gov/guidelines on 10/19/2019
Developed by the HHS Panel on Antiretroviral Therapy and Medical Management of Children Living with HIV—A Working Group of the Office
of AIDS Research Advisory Council (OARAC)
Estas directrices sustituyen a los anteriores documentos de política de la OMS sobre el manejo de la ILTB en las personas con la infección por el VIH, los contactos del hogar de personas con TB y otros grupos de riesgo. Las Directrices unificadas de la OMS sobre la tuberculosis: Tratamiento preven...
AIDS Research and Therapy 2015, 12:12 (24 April 2015)
PLOS ONE | DOI:10.1371/journal.pone.0144057 December 14, 2015
Developed by the HHS Panel on Treatment of Pregnant Women with HIV Infection and Prevention of Perinatal Transmission—
A Working Group of the Office of AIDS Research Advisory Council (OARAC)
Accessed: 12.02.2020
Accessed: 20.10.2019
Downloaded from https://aidsinfo.nih.gov/guidelines on 11/27/2019
Visit the AIDSinfo website to access the most up-to-date guideline.
Register for e-mail notification of guideline updates at https://aidsinfo.nih.gov/e-news.
Module 12:
Adolescents and young adults
July 2018
Module 12: Adolescents and young adults. This module is for people who are interested in providing PrEP services to older adolescents and young adults who are at substantial risk for HIV. It provides information on: factors that influence HIV...
1.HIV infections – drug therapy. 2.Anti-HIV agents – adverse effects. 3.Anti-retroviral agents. 4.Benzoxazines – adverse effects. 5.Pregnancy. 6.Disease transmission, Vertical - prevention and control. 7.Treatment outcome. I.World Health Organization
Journal of Infection and Public Health 12 (2019) 213–223
Recomendaciones para un enfoque de salud pública
Segunda edición 2016
J Acquir Immune Defic Syndr Volume 78, Supplement 1, August 15, 2018
Definition and categorization of the time of vertical transmission of SARS-CoV-2
Scientific report 8 February 2021
WHO and UNITAID
in collaboration with IMPAACT (International Maternal Pediatric Adolescent AIDS Clinical Trials) network, PENTA (Paediatric European Network for Treatment of AIDS) foundation and experts from the Paediatric Antiretroviral Working Group
The WHO COVID-19 LENS (Living Evidence Synthesis) working group consolidated available evidence, based on rapid reviews of the literature and results of a living systematic review on pregnancy and COVID-19 (up to October 7, 2020), on potential mechanisms of vertical transmission of infectious pathog...
